Login

Creating, facilitating, and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

RCROT02 – Rapid Collaborative Review on the diagnostic accuracy of molecular methods that detect the presence of SARS-CoV-2 virus in people with suspected COVID-19 – Project Plan now available

By admin  / July 31, 2020
RCROT02 – Rapid Collaborative Review on the diagnostic accuracy of molecular methods that detect the presence of SARS-CoV-2 virus in people with suspected COVID-19 – Project Plan now available

OTCA23 Final Assessment Report “Biodegradable rectum spacers to reduce toxicity for prostate cancer” now available

By admin  / July 31, 2020
OTCA23 Final Assessment Report “Biodegradable rectum spacers to reduce toxicity for prostate cancer” now available

OTCA27 – Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia (BPH)- project plan now available

By admin  / July 31, 2020
OTCA27 – Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia (BPH)- project plan now available

PTJA12 – Glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (AML) in adult patients who are not candidates for standard induction chemotherapy – Final assessment now available

By admin  / July 30, 2020
PTJA12 – Glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (AML) in adult patients who are not candidates for standard induction chemotherapy – Final assessment now available

PTJA10 – crizanlizumab indicated for the prevention of recurrent vast-occlusive crises in sickle cell disease patients aged 16 years and over – project plan now available

By admin  / July 28, 2020

Custom icon
Early Dialogues

Custom icon
Submission & Methodology

Custom icon
Assessments

Custom icon
National Implementation

Services

Assessments

Tools

Have Questions? Check our FAQ